Senior Vice President and General Counsel · BIO-TECHNE Corp (TECH)

Shane Bohnen

A named executive officer of BIO-TECHNE in every fiscal year CompBrief holds from FY2023 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$1,980,732

FY2024: $1,455,793

5th of 5 named executive officers at BIO-Techne by FY2025 total.

5 named officers on file for BIO-TECHNE, FY2025

See an example →

What this number hides

The filing gives the total. BIO-TECHNE’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Compensation figures as of the proxy filed September 19, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-07.

Free

Get Shane Bohnen’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Shane Bohnen and every company like it: Velarion Intel, free for 3 days, no card →

Shane Bohnen compensation by year

BIO-TECHNE Summary Compensation Table · all 3 fiscal years held
In US dollars, as BIO-TECHNE reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024FY2025
Salary$331,500$344,760$431,000
Bonus$0$0$0
Stock awards$499,945$262,517$767,575
Option awards$190,699$762,509$377,496
Non-equity incentive$22,100$76,020$386,478
Pension and deferred compensation$0$0$0
All other$0$9,988$18,183
Total$1,044,244$1,455,793$1,980,732

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIO-TECHNE Corp DEF 14A filed September 19, 2025, accession 0001308179-25-000599, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BIO-TECHNE Corp filed document, accession 0001308179-25-000599. Every figure is read from that document and cited to the page and table it appears in. Filed September 19, 2025.

$1.0M
$1.5M
$2.0M
FY23
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU4,519$323,786—
PSU4,432$317,553—
RSU148$10,604—
Option16,302—$84.61
Option1,728—$120.46
Option2,236—$66.97
Option2,632—$94.52
Option2,946—$73.76

Per the Outstanding Equity Awards at Fiscal Year-End table in BIO-TECHNE Corp's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

27 Form 4 lines since the FY2025 proxy (filed September 19, 2025)
current to 2026-11-07 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-08-17Grant or award derivative—11,344$0.0011,344
2026-08-17Grant or award derivative—18,432$0.0018,432
2026-08-15Exercise or conversion—4,420$0.0011,773
2026-08-15Disposition to the issuer derivative—12,117$0.00807
2026-08-15Tax withholding—1,343$72.4010,360
2026-08-15Exercise or conversion derivative—49$0.000
2026-08-15Exercise or conversion derivative—300$0.004,502
2026-08-15Disposition to the issuer derivative—4,502$0.000

The 8 most recent of 27 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

BIO-TECHNE’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Kim KeldermanPresident and CEO$8,151,181
James HippelExecutive Vice President and CFO$7,027,382
William GeistPresident, Protein Sciences$3,139,299
Matthew McManusPresident, Diagnostics and Spatial Biology$2,846,619
Shane Bohnen · this pageSenior Vice President and General Counsel$1,980,732

The full BIO-TECHNE compensation record

free company brief

This page is one person within BIO-TECHNE's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BIO-TECHNE proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order BIO-TECHNE's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIO-TECHNE's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order TECH

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Shane Bohnen's compensation dossier